Heart attack

March 31, 2018

Treating cardiac diseases with branched-chain amino acids:  Branched chain amino acid-based therapy for Cardiomyopathy: A therapeutic mix encompassing branched chain amino acids (10g) decrease the expression of Sox6, restore the balance between slow- and fast-twitch myofiber proteins and alleviate Cardiomyopathy via up regulation of its target gene, 31/March/2018, 11.08 pm

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]
March 31, 2018

Managing glaucoma with branched chain amino acids: Branched chain amino acids increase Nmnat1 expression, increase NAD+ levels, improve neuronal dysfunction, and protect against glaucoma via down regulation of its target gene, 31/March/2018,  9.29 pm

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]
March 30, 2018

Managing heart diseases with essential amino acids:  Essential amino acid-based therapy for Cardiomyopathy: A therapeutic mix encompassing essential amino acids (10g) decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 31/March/2018, 12.01 am

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]
March 30, 2018

A sweet way to protect your heart: Trisaccharide-based therapy for Myocardial Infarction: Raffinose, a trisaccharide composed of galactose, glucose, and fructose, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 30/March/2018, 10.54 pm

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of of […]